1-8 of 8
Sridhar K. Rabindran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-42: PDK1 knockdown selectively inhibits growth of cancer cells harboring activating mutations involved in MAPK signaling

M. Phillip DeYoung, Christine M. Gardiner, Antony R. Chadderton, Jesus R. Medina, Jeffrey M. Axten, Sridhar K. Rabindran
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-42.
https://doi.org/10.1158/1538-7445.AM10-LB-42
Published: 15 April 2010
View article titled, Abstract LB-42: PDK1 knockdown selectively inhibits growth of cancer cells harboring activating mutations involved in MAPK signaling
Journal Articles

Antitumor activity of the enediyne chromoprotein, 21G792: A small molecule-protein complex

Sridhar K. Rabindran, Valerie Bernan, Carolyn M. Discafani, Bradley A. Haltli, Ying X. Huang, Margaret Leighton, John P. McGinnis, Miriam Miranda, Yongchang Qiu, Edward C. Rosfjord, Jiang Wu, Hui Yang, Haiyin He
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 896–897.
Published: 15 April 2006
View article titled, Antitumor activity of the enediyne chromoprotein, 21G792: A small molecule-protein complex
Journal Articles

The value of isogenic cell lines in cancer drug discovery: Antitumor activity of WAY-181484, an orally-active, microtubule-binding agent

Sridhar K. Rabindran, Carl Beyer, Carolyn M. Discafani, John P. McGinnis, Miriam Miranda, Ariamala Gopalsamy, Girija Krishnamurthy, Dennis Powell, Daniel Wang, Nan Zhang
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1394.
Published: 01 May 2005
View article titled, The value of isogenic cell lines in cancer drug discovery: Antitumor activity of WAY-181484, an orally-active, microtubule-binding agent
Journal Articles

Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides-novel antiproliferative agents

Dennis Powell, Ariamala Gopalsamy, Yanong D. Wang, Hwei-Ru Tsou, Nan Zhang, Erick Honores, Steve Johnson, Biqi Wu, Miriam Miranda, John P. McGinnis, Sridhar K. Rabindran, John W. Ellingboe
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 153.
Published: 01 May 2005
View article titled, Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides-novel antiproliferative agents
Journal Articles

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

Sridhar K. Rabindran, Carolyn M. Discafani, Edward C. Rosfjord, Michelle Baxter, M. Brawner Floyd, Jonathan Golas, William A. Hallett, Bernard D. Johnson, Ramaswamy Nilakantan, Elsebe Overbeek, Marvin F. Reich, Ru Shen, Xiaoqing Shi, Hwei-Ru Tsou, Yu-Fen Wang, Allan Wissner
Journal: Cancer Research
Cancer Res (2004) 64 (11): 3958–3965.
https://doi.org/10.1158/0008-5472.CAN-03-2868
Published: 01 June 2004
View article titled, Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
Open the PDF for Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase in another window
Journal Articles

Fumitremorgin C Reverses Multidrug Resistance in Cells Transfected with the Breast Cancer Resistance Protein

Sridhar K. Rabindran, Douglas D. Ross, L. Austin Doyle, Weidong Yang, Lee M. Greenberger
Journal: Cancer Research
Cancer Res (2000) 60 (1): 47–50.
Published: 01 January 2000
View article titled, Fumitremorgin C Reverses Multidrug Resistance in Cells Transfected with the Breast Cancer Resistance Protein
Open the PDF for Fumitremorgin C Reverses Multidrug Resistance in Cells Transfected with the Breast Cancer Resistance Protein in another window
Journal Articles

Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C

Sridhar K. Rabindran, Haiyin He, Maya Singh, Eileen Brown, Karen I. Collins, Tami Annable, Lee M. Greenberger
Journal: Cancer Research
Cancer Res (1998) 58 (24): 5850–5858.
Published: 01 December 1998
View article titled, Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C
Open the PDF for Reversal of a Novel Multidrug Resistance Mechanism in Human Colon Carcinoma Cells by Fumitremorgin C in another window
Journal Articles

Abrogation of the Rb/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas

Mieke Schutte, Ralph H. Hruban, Joseph Geradts, Rob Maynard, Werner Hilgers, Sridhar K. Rabindran, Christopher A. Moskaluk, Stephan A. Hahn, Irmgard Schwarte-Waldhoff, Wolff Schmiegel, Stephen B. Baylin, Scott E. Kern, James G. Herman
Journal: Cancer Research
Cancer Res (1997) 57 (15): 3126–3130.
Published: 01 August 1997
View article titled, Abrogation of the Rb/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas
Open the PDF for Abrogation of the Rb/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas in another window